In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thoratec Seeks Therapeutic VAD, Others Aim For Alternative-To-Transplant

This article was originally published in The Gray Sheet

Executive Summary

Thoratec plans to file a PMA supplement for a therapeutic recovery indication for the Thoratec ventricular assist device (VAD) by year-end.

You may also be interested in...



Abiomed Pumps Cash Into Eleventh-Hour Bid For Thermo CardioSystems

Abiomed may be able to leverage its strength in the capital markets - specifically, an enhanced cash position resulting from a $95 mil. secondary offering last March - to undercut a previously announced all-stock bid by Thoratec for ventricular assist device developer Thermo CardioSystems.

Abiomed Pumps Cash Into Eleventh-Hour Bid For Thermo CardioSystems

Abiomed may be able to leverage its strength in the capital markets - specifically, an enhanced cash position resulting from a $95 mil. secondary offering last March - to undercut a previously announced all-stock bid by Thoratec for ventricular assist device developer Thermo CardioSystems.

WorldHeart Gaining Access To U.S. VAD Market Via Edwards' Novacor

WorldHeart will gain immediate access to the U.S. left ventricular assist device market through Edwards Lifesciences' Novacor ventricular assist system under a definitive licensing agreement announced May 25.

Related Content

UsernamePublicRestriction

Register

MT013797

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel